Status:
COMPLETED
Hypoglycemia and Autonomic Nervous System Function
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Beth Israel Deaconess Medical Center
National Institutes of Health (NIH)
Conditions:
Hypoglycemia
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The goals of this proposal are to determine the effects of hypoglycemia on the autonomic nervous system.
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Healthy volunteers
- Males and females age 18 to 50 years
- Exclusion Criteria
- Pregnancy
- Lactation
- Subjects who smoke or are on other forms of nicotine will be excluded
- Clinically evident coronary artery, cerebrovascular, or peripheral vascular disease, or presence of systemic illness that might affect autonomic function. Such illnesses include diabetes mellitus, congestive heart failure, hypertension, renal, pulmonary, hepatic disease, anemia, malignancies, untreated thyroid disease, and alcoholism.
- Current major depressive illness
- Any individuals on oral, injected, inhaled or topical corticosteroids within the last year or oral contraceptives within the past 3 months will be excluded.
- Use of medications other than thyroxine
Exclusion
Key Trial Info
Start Date :
June 8 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 6 2007
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT01816893
Start Date
June 8 2004
End Date
November 6 2007
Last Update
April 2 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02115
2
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115